Alisertib and Combination Chemotherapy in Treating Patients With Gastrointestinal Tumors

NCT02319018 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

14

Enrollment

NIH

Sponsor class

Conditions

Malignant Digestive System Neoplasm

Interventions

DRUG: Alisertib
DRUG: Fluorouracil
OTHER: Laboratory Biomarker Analysis
DRUG: Leucovorin Calcium
DRUG: Oxaliplatin

Sponsor

National Cancer Institute (NCI)